Company: OSRH
Filing Date: 2025-01-31
Form Type: 424B3
Source: 0001213900-25-008874
Chunk: 323

Company: OSR Holdings, Inc.
Filing Date: 2025-01-31
Form: 424B3
Chunk 323
---
 the aforementioned persons that are not described in this proxy statement and that would affect the vote on the Business Combination Proposal. See “ Risk Factors — Risks Related to the Business Combination and Business Combination Agreement — The Sponsor and its affiliates may enter into agreements concerning BLAC’s securities prior to the special meeting, which may have the effect of increasing the likelihood of completion of the Business Combination or decreasing the value of BLAC Common Stock.” 192 Regulatory Approvals Required for the Business Combination Other than as described immediately below, neither of BLAC or OSR Holdings is aware of any material regulatory approvals or actions that are required for completion of the Business Combination. It is presently contemplated that if any regulatory approvals or actions are required, those approvals or actions will be sought. There can be no assurance, however, that any additional approvals or actions will be obtained. Because BLAC’s Sponsor is controlled by and has substantial ties with non -U.S. persons, and will own approximately 11.6% of the issued and outstanding BLAC Common Stock following the Business Combination (assuming that all of BLAC’s public stockholders exercise redemption rights), we may be considered a “foreign person” under rules promulgated by CFIUS, and the Business Combination may fall within the scope of a “covered transaction” subject to CFIUS review. See “ Risk Factors — Risks Related to the Business Combination and Business Combination Agreement— We may not be able to complete an initial business combination with a U.S. target company since such initial business combination may be subject to U.S. foreign investment regulations and review by a U.S. government entity such as CFIUS, and ultimately prohibited.” Litigation Relating to the Business Combination There have been no proceedings brought against BLAC in relation to the Business Combination or the Business Combination Agreement. Listing of the Combined Company Securities Approval of the listing on Nasdaq of the Combined Company securities to be issued in the Business Combination, subject to official notice of issuance, is a condition to each party’s obligation to complete the Business Combination. Accounting Treatment The Business Combination will be accounted for as a reverse recapitalization in accordance with U.S. GAAP and ASC which is the current single source of U.S. GAAP. Under this method of accounting, BLAC will be treated as the “acquired” company and OSR Holdings will be considered the accounting acquirer for accounting purposes as set forth by the guidance in ASC 805 -10. This conclusion is supported by the voting interest model referenced in ASC 805 -10-